Why the study?
The study was conducted to evaluate the clinical efficacy and quality of life of indapamide in patients with mild and moderate arterial systemic hypertension.
Does indapamide monotherapy reduce blood pressure and improve quality of life in patients with mild and moderate arterial systemic hypertension?
Does indapamide monotherapy reduce blood pressure and improve quality of life in patients with mild and moderate arterial systemic hypertension?
Answers are grounded in this paper and cite their sources.
Indapamide 2.5 mg daily effectively lowers blood pressure and improves quality of life in patients with mild to moderate hypertension.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
A 2019 study studied mild and moderate arterial systemic hypertension (n=32). Indapamide vs. Baseline was evaluated on Mean supine systolic/diastolic blood pressure (p=<0.0001).
Synapse has enriched 10 related papers. Consider them for comparative context: